PL1853251T3 - Halogenopodstawione boronoftalidy do leczenia infekcji - Google Patents

Halogenopodstawione boronoftalidy do leczenia infekcji

Info

Publication number: PL1853251T3
Authority: PL; Poland
Prior art keywords: boronophthalides; infections; halogen; substituted; treatment
Prior art date: 2005-02-16

Application number

PL06735282T

Other languages

English (en)

Inventor

Stephen J Baker

Tsutomu Akama

Carolyn Bellinger-Kawahara

Vincent S Hernandez

Karin M Hold

James J Leyden

Kirk R Maples

Jacob J Plattner

Virginia Sanders

Yong-Kang Zhang

Gregory Fieldson

Original Assignee

Anacor Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-16

Filing date

2006-02-16

Publication date

2013-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36917059&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1853251(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-02-16 Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc

2013-09-30 Publication of PL1853251T3 publication Critical patent/PL1853251T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/05—Cyclic compounds having at least one ring containing boron but no carbon in the ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Endocrinology (AREA)
Ophthalmology & Optometry (AREA)
Physical Education & Sports Medicine (AREA)
AIDS & HIV (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL06735282T 2005-02-16 2006-02-16 Halogenopodstawione boronoftalidy do leczenia infekcji PL1853251T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US65406005P	2005-02-16	2005-02-16
PCT/US2006/005542 WO2006089067A2 (en)	2005-02-16	2006-02-16	Boron-containing small molecules
EP06735282.3A EP1853251B1 (en)	2005-02-16	2006-02-16	Halogen-substituted boronophthalides for the treatment of infections

Publications (1)

Publication Number	Publication Date
PL1853251T3 true PL1853251T3 (pl)	2013-09-30

Family

ID=36917059

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
PL15171026T PL2987796T3 (pl)	2005-02-16	2006-02-16	Fluorowco-podstawione boronoftalidy do leczenia zakażeń
PL11154575T PL2343304T3 (pl)	2005-02-16	2006-02-16	Biobójcze związki boronoftalidowe
PL18187390T PL3424932T3 (pl)	2005-02-16	2006-02-16	Boronoftalidy do zastosowania terapeutycznego
PL06735282T PL1853251T3 (pl)	2005-02-16	2006-02-16	Halogenopodstawione boronoftalidy do leczenia infekcji

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
PL15171026T PL2987796T3 (pl)	2005-02-16	2006-02-16	Fluorowco-podstawione boronoftalidy do leczenia zakażeń
PL11154575T PL2343304T3 (pl)	2005-02-16	2006-02-16	Biobójcze związki boronoftalidowe
PL18187390T PL3424932T3 (pl)	2005-02-16	2006-02-16	Boronoftalidy do zastosowania terapeutycznego

Country Status (26)

Country	Link
US (11)	US7582621B2 (pl)
EP (4)	EP3424932B1 (pl)
JP (6)	JP5038912B2 (pl)
KR (4)	KR101337068B1 (pl)
CN (2)	CN101914109B (pl)
AU (3)	AU2006214247C1 (pl)
BR (1)	BRPI0608431B8 (pl)
CA (1)	CA2597982C (pl)
CY (3)	CY1120695T1 (pl)
DK (3)	DK2987796T3 (pl)
ES (4)	ES2540966T3 (pl)
FR (1)	FR20C1024I2 (pl)
HK (3)	HK1109735A1 (pl)
HU (4)	HUE040060T2 (pl)
IL (2)	IL185080A (pl)
LT (1)	LTC2343304I2 (pl)
LU (1)	LUC00157I2 (pl)
MX (1)	MX369262B (pl)
NL (1)	NL301049I2 (pl)
NZ (3)	NZ578297A (pl)
PL (4)	PL2987796T3 (pl)
PT (4)	PT2987796T (pl)
RU (3)	RU2414906C2 (pl)
SI (3)	SI3424932T1 (pl)
WO (1)	WO2006089067A2 (pl)
ZA (4)	ZA200707408B (pl)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7820186B2 (en) *	2001-12-21	2010-10-26	Galderma Research & Development	Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
MX369262B (es) *	2005-02-16	2019-11-04	Anacor Pharmaceuticals Inc	Moleculas pequeñas que contienen boro.
US7793666B2 (en) *	2005-07-28	2010-09-14	Innovation Biomedical Devices, Inc.	Apparatus and method for treatment of infected nail
WO2007078340A2 (en)	2005-12-30	2007-07-12	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
CN103479654B (zh) *	2006-02-16	2018-02-09	安纳考尔医药公司	作为抗炎药的含硼的小分子
CA2651212A1 (en) *	2006-05-02	2007-11-15	Anacor Pharmaceuticals, Inc.	Hydrolytically-resistant boron-containing therapeutics and methods of use
EP1900378A1 (en) *	2006-08-31	2008-03-19	Novartis AG	Pharmaceutical compositions for the treatment of fungal infections
JO3598B1 (ar)	2006-10-10	2020-07-05	Infinity Discovery Inc	الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
FR2910320B1 (fr) *	2006-12-21	2009-02-13	Galderma Res & Dev S N C Snc	Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr)	2006-12-21	2009-07-10	Galderma Res & Dev S N C Snc	Gel creme comprenant au moins un retinoide et du peroxyde de benzole
JO3396B1 (ar)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
US20090175810A1 (en)	2008-01-03	2009-07-09	Gareth Winckle	Compositions and methods for treating diseases of the nail
JP2015178508A (ja) *	2008-01-09	2015-10-08	アナコールファーマシューティカルズ，インコーポレイテッド	抗炎症剤としてのホウ素含有小分子
WO2009111676A2 (en) *	2008-03-06	2009-09-11	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-inflammatory agents
EP3246034A1 (en)	2008-03-06	2017-11-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-inflammatory agents
CN102046179B (zh)	2008-04-09	2015-01-14	英菲尼提制药公司	脂肪酸酰胺水解酶抑制剂
EP2285384A4 (en) *	2008-05-12	2012-04-25	Anacor Pharmaceuticals Inc	BORN SMALL MOLECULES
US20100021530A1 (en) *	2008-07-25	2010-01-28	Innovation Biomedical Devices, Inc.	Enhanced trans-keratin drug delivery
WO2010027975A1 (en) *	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010028005A1 (en)	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010045503A1 (en) *	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents
BRPI0922566A2 (pt) *	2008-12-17	2017-03-28	Anacor Pharmaceuticals Inc	polimorfo cristalino, composição farmacêutica, composto, e, métodos para preparar um composto, e para tratar uma doença.
ES2493916T3 (es)	2009-04-07	2014-09-12	Infinity Pharmaceuticals, Inc.	Inhibidores de hidrolasa de amida de ácidos grasos
AU2010234449A1 (en)	2009-04-07	2011-11-03	Infinity Pharmaceuticals, Inc.	Inhibitors of fatty acid amide hydrolase
US8343944B2 (en) *	2009-07-28	2013-01-01	Anacor Pharmaceuticals, Inc.	Trisubstituted boron-containing molecules
US9440994B2 (en) *	2009-08-14	2016-09-13	Anacor Pharmaceuticals, Inc.	Boron containing small molecules as antiprotozoal agents
WO2011019616A1 (en)	2009-08-14	2011-02-17	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
WO2011019612A1 (en)	2009-08-14	2011-02-17	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
WO2011022337A1 (en)	2009-08-19	2011-02-24	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
US20110124597A1 (en) *	2009-09-25	2011-05-26	Anacor Pharmaceuticals, Inc.	Boron containing small molecules
US8979820B2 (en)	2009-10-09	2015-03-17	Cynthia S. Bailey	Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes
US9346834B2 (en)	2009-10-20	2016-05-24	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antiprotozoal agents
WO2011060196A1 (en)	2009-11-11	2011-05-19	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2011063293A1 (en)	2009-11-20	2011-05-26	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as antihelminth agents
US8716478B2 (en)	2010-01-27	2014-05-06	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
MX361692B (es)	2010-02-03	2018-12-13	Infinity Pharmaceuticals Inc	Inhibidores de amida hidrolasa de ácido graso.
AP2012006482A0 (en)	2010-03-19	2012-10-31	Anacor Pharmacueticals Inc	Boron-containing small molecules as anti-protozoalagent
US8039494B1 (en)	2010-07-08	2011-10-18	Dow Pharmaceutical Sciences, Inc.	Compositions and methods for treating diseases of the nail
SMT202000248T1 (it)	2010-08-10	2020-07-08	Rempex Pharmaceuticals Inc	Derivati di estere di acido boronico ciclico e relativi usi terapeutici
JP5952280B2 (ja)	2010-09-07	2016-07-13	アナコールファーマシューティカルズ，インコーポレーテッド	細菌感染治療用のベンゾオキサボロール誘導体
WO2013033461A1 (en)	2011-08-31	2013-03-07	Rempex Pharmaceuticals, Inc.	Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
US9162999B2 (en)	2011-09-28	2015-10-20	Wisconsin Alumni Research Foundation	Catalytic conversion of cellulose to fuels and chemicals using boronic acids
CA2850263A1 (en)	2011-10-07	2013-04-11	Syngenta Participations Ag	Method for protecting useful plants or plant propagation material
AR088668A1 (es) *	2011-11-21	2014-06-25	Lilly Co Eli	Moleculas pequeñas que contienen boro
AR088669A1 (es)	2011-11-21	2014-06-25	Lilly Co Eli	Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
US9156858B2 (en)	2012-05-23	2015-10-13	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
US10561675B2 (en)	2012-06-06	2020-02-18	Rempex Pharmaceuticals, Inc.	Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2014007831A1 (en)	2012-07-06	2014-01-09	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
US9101638B2 (en)	2013-01-04	2015-08-11	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
CA2894891A1 (en)	2013-01-04	2014-07-10	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
CN104981239B (zh)	2013-01-04	2019-01-04	莱姆派克斯制药公司	硼酸衍生物及其治疗用途
US9241947B2 (en)	2013-01-04	2016-01-26	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
AU2014212576B2 (en)	2013-01-30	2015-08-13	Agrofresh Inc.	Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US8669207B1 (en) *	2013-01-30	2014-03-11	Dow Agrosciences, Llc.	Compounds and compositions
US9585396B2 (en)	2013-01-30	2017-03-07	Agrofresh Inc.	Volatile applications against pathogens
US11039617B2 (en)	2013-01-30	2021-06-22	Agrofresh Inc.	Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en)	2013-01-30	2018-09-11	Agrofresh Inc.	Volatile applications against pathogens
US9446131B2 (en)	2013-01-31	2016-09-20	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US9452173B2 (en)	2013-01-31	2016-09-27	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US9433680B2 (en)	2013-01-31	2016-09-06	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US8778365B1 (en)	2013-01-31	2014-07-15	Merz Pharmaceuticals, Llc	Topical compositions and methods for making and using same
US9598443B2 (en)	2013-02-01	2017-03-21	Anacor Pharmaceuticals, Inc.	Boron containing small molecules as antiprotozoal agents
AR094961A1 (es) *	2013-03-15	2015-09-09	Lilly Co Eli	1-hidroxi-benzooxaboroles como agentes antiparasitarios
AU2014202928B1 (en) *	2013-06-05	2014-09-11	Agrofresh Inc.	Compounds and compositions
CN104224810B (zh) *	2013-06-20	2017-04-19	中国科学院上海生命科学研究院	一种化合物及其衍生物治疗肺炎球菌感染性疾病的用途
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
JP6499175B2 (ja)	2013-08-09	2019-04-10	グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙ（Ｎｏ．２）Ｌｉｍｉｔｅｄ	三環式ベンゾキサボロール化合物及びその使用
CA2924748C (en)	2013-10-03	2019-09-03	Dow Pharmaceutical Sciences, Inc.	Stabilized efinaconazole formulations
CA2931144C (en)	2013-11-22	2020-02-04	Dow Pharmaceutical Sciences, Inc.	Anti-infective methods, compositions, and devices
UY36000A (es) *	2014-02-17	2015-09-30	Syngenta Participations Ag	?compuestos microbicidas, método para controlar o prevenir la infestación de microorganismos fitopa togenos, y composición de los mismos?.
US10065029B2 (en)	2014-03-03	2018-09-04	Cook Medical Technologies Llc	Mechanical dilator
JP2015212249A (ja) *	2014-05-05	2015-11-26	アナコールファーマシューティカルズ，インコーポレイテッド	化合物および爪光沢剤
US9687497B1 (en)	2014-05-05	2017-06-27	Rempex Pharmaceuticals, Inc.	Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
RS59488B1 (sr)	2014-05-05	2019-12-31	Rempex Pharmaceuticals Inc	Sinteza boronatnih soli i njihove upotrebe
MX2016014853A (es) *	2014-05-12	2017-04-06	Agrofresh Inc	Aplicaciones volatiles contra patogenos.
US9963467B2 (en)	2014-05-19	2018-05-08	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
WO2016001834A1 (en)	2014-07-01	2016-01-07	Daiichi Sankyo Company, Limited	Tricyclic benzoxaboroles as antibacterial agents
JP6700203B2 (ja)	2014-07-01	2020-05-27	レンペックス・ファーマシューティカルズ・インコーポレイテッド	ボロン酸誘導体およびその治療的使用
RS62386B1 (sr)	2014-10-21	2021-10-29	Hexima Ltd	Postupak za lečenje gljivičnih infekcija
WO2016081297A1 (en)	2014-11-18	2016-05-26	Rempex Pharmaceuticals, Inc.	Cyclic boronic acid ester derivatives and therapeutic uses thereof
MA41495A (fr)	2015-02-12	2017-12-19	Anacor Pharmaceuticals Inc	Composés benzoxaborole et leurs utilisations
WO2016149393A1 (en)	2015-03-17	2016-09-22	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
KR101580077B1 (ko) *	2015-03-28	2015-12-24	한국콜마주식회사	시크로피록스 함유 네일락카 조성물
CA2981773C (en)	2015-04-09	2022-03-15	The Penn State Research Foundation	Synergistic benzoxaborole-containing anti-fungicidal composition
JP2018514519A (ja)	2015-04-09	2018-06-07	アナコールファーマシューティカルズ，インコーポレーテッド	抗原虫剤としてのホウ素含有小分子
WO2016201440A1 (en) *	2015-06-12	2016-12-15	The Regents Of The University Of California	Spiroindolinones and therapeutic uses thereof
WO2017024022A1 (en) *	2015-08-06	2017-02-09	The Penn State Research Foundation	Benzoxaborole-containing coating resistant to cellulose-supportable fungus
CN106467557B (zh) *	2015-08-18	2019-05-03	北京海美桐医药科技有限公司	他瓦硼罗的一种制备方法
SI3383363T1 (sl)	2015-11-30	2021-03-31	Anacor Pharmaceuticals, Inc.	Topične farmacevtske formulacije za zdravljenje vnetnih bolezenskih stanj
US10874679B2 (en)	2016-03-02	2020-12-29	Bill & Melinda Gates Foundation	Boron-containing small molecules
EP3423159A4 (en) *	2016-03-02	2019-11-06	Anacor Pharmaceuticals, Inc.	BORN SMALL MOLECULES
EP3423065B1 (en) *	2016-03-02	2021-07-21	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
TW201733442A (zh)	2016-03-07	2017-10-01	農業保鮮股份有限公司	殺有害生物劑之汽化給予
WO2017155879A1 (en)	2016-03-07	2017-09-14	Agrofresh Inc.	Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
AU2017262235C1 (en) *	2016-05-09	2020-08-20	Anacor Pharmaceuticals, Llc	Crystal forms of crisaborole in free form and preparation method and use thereof
US11447506B2 (en)	2016-05-09	2022-09-20	Anacor Pharmaceuticals, Inc.	Crystal forms of crisaborole in free form and preparation method and use thereof
EP3478693B1 (en)	2016-06-30	2021-07-21	Qpex Biopharma, Inc.	Boronic acid derivatives and therapeutic uses thereof
US20170305936A1 (en)	2016-07-12	2017-10-26	Pliva Hrvatska D.O.O.	Solid state forms of crisaborole
US10743232B1 (en)	2016-11-15	2020-08-11	Sprint Spectrum L.P.	Controlling handover based on carrier-aggregation policies and UE capabilities
WO2018115362A1 (en)	2016-12-22	2018-06-28	Laboratorios Lesvi, Sl	Process for preparing 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile (crisaborole)
GB201701583D0 (en) *	2017-01-31	2017-03-15	Drug Delivery Solutions Ltd	Topical composition
WO2018150327A1 (en) *	2017-02-14	2018-08-23	Wavelength Enterprises Ltd	Crisaborole production process
EP3576747A4 (en) *	2017-03-09	2020-12-16	The Penn State Research Foundation	SMALL MOLECULES CONTAINING BORON TO INHIBIT THE ACTIVITY OF A RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE
WO2018207216A1 (en)	2017-05-12	2018-11-15	Biophore India Pharmaceuticals Pvt. Ltd.	Novel process for the preparation of 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl) oxy] benzonitrile (crisaborole)
US10865217B2 (en)	2017-05-23	2020-12-15	Msn Laboratories Private Limited, R & D Center	Process for the preparation of 5-(4-cyanophenoxy)-1,3-dihydro-1-hydroxy-[2,1]-benzoxaborole and polymorphs thereof
CA3078627A1 (en)	2017-10-11	2019-04-18	Qpex Biopharma, Inc.	Boronic acid derivatives and synthesis thereof
ES2963960T3 (es)	2017-11-02	2024-04-03	Halcyon Labs Private Ltd	Procedimiento nuevo para la preparación de Tavaborol y sus intermediarios
CA3120976A1 (en)	2017-11-30	2019-06-06	Boragen, Inc.	Benzoxaborole compounds and formulations thereof
US10329311B1 (en)	2017-12-21	2019-06-25	Olon S.P.A.	Process for the preparation of crisaborole
CN108148085B (zh)	2018-01-04	2019-11-01	合肥医工医药股份有限公司	具有抑制磷酸二酯酶4的化合物、制法及其药物用途
ES2949908T3 (es)	2018-01-09	2023-10-03	Halcyon Labs Private Ltd	Proceso para la preparación de Crisaborol y sus intermedios
US10597410B2 (en)	2018-02-02	2020-03-24	Dipharma Francis S.R.L.	Intermediates and process for the preparation of a crystalline form of a topical anti-inflammatory agent
CN108451898A (zh) *	2018-04-03	2018-08-28	苏州尚宜佳生物科技有限公司	一种克立硼罗温敏凝胶剂及其制备方法和应用
WO2019204419A1 (en)	2018-04-20	2019-10-24	The Medicines Company (San Diego), Llc	Boronic acid derivatives and therapeutic uses thereof
GB201809378D0 (en)	2018-06-07	2018-07-25	Glaxosmithkline Ip Dev Ltd	Novel compounds
CN108659024A (zh) *	2018-07-24	2018-10-16	武汉轻工大学	克立硼罗的制备方法
CN112384201A (zh) *	2018-07-31	2021-02-19	Mc2疗法有限公司	局部组合物
BR112021003037A2 (pt)	2018-08-18	2021-05-11	Boragen, Inc.	formas sólidas de benzoxaborol substituído e composições do mesmo
MA53808A (fr) *	2018-10-05	2022-01-12	Pfizer	Inhibiteurs de pde4 contenant du bore
WO2020187803A1 (en)	2019-03-20	2020-09-24	Rita Dobmeyer	Pharmaceutical composition
US12065456B2 (en) *	2019-07-25	2024-08-20	National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government	Boron-containing pharmacophore
CN110664756B (zh) *	2019-10-09	2020-11-17	吉林大学	一种小儿外伤喷雾剂及其制备方法
WO2022043936A1 (en)	2020-08-31	2022-03-03	Pfizer Inc.	Methods of protecting rna
CN114644645B (zh) *	2022-03-08	2023-05-26	南京农业大学	3-吲哚取代苯硼唑类化合物及其制备方法和应用
WO2023246841A1 (en) *	2022-06-23	2023-12-28	Shanghai Micurx Pharmaceutical Co., Ltd.	Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
GB202306663D0 (en)	2023-05-05	2023-06-21	Union Therapeutics As	Combination therapy

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2260336A (en)	1939-10-16	1941-10-28	Dow Chemical Co	Method of preparation of organic borates
US3686398A (en)	1970-07-20	1972-08-22	Chevron Res	10,9-boroxarophenanthrene as fungicides
GB1396904A (en) *	1972-08-11	1975-06-11	Ici Ltd	Method for the control of micro-organisms
US4766113A (en)	1975-10-24	1988-08-23	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4602011A (en)	1975-10-24	1986-07-22	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4716035A (en)	1985-05-24	1987-12-29	The Procter & Gamble Company	Oral compositions and methods for treating gingivitis
US5962498A (en)	1986-06-11	1999-10-05	Procyon Pharmaceuticals, Inc.	Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en)	1987-01-30	1990-01-16	Colgate-Palmolive Company	Antibacterial antiplaque oral composition
US4919934A (en)	1989-03-02	1990-04-24	Richardson-Vicks Inc.	Cosmetic sticks
US5514696A (en) *	1992-05-06	1996-05-07	Bristol-Myers Squibb Co.	Phenyl sulfonamide endothelin antagonists
SG47101A1 (en)	1992-07-31	1998-03-20	Us Bioscience	Crystalline amifostine compositions and methods for the preparation and use of same
US5348947A (en)	1993-05-07	1994-09-20	American Cyanamid Company	Diarylboron ester and thioester fungicidal agents
US5348948A (en)	1993-05-07	1994-09-20	American Cyanamid Company	2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5594151A (en)	1994-01-28	1997-01-14	Prolinx, Inc.	Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) *	1994-06-09	1994-08-03	Zeneca Ltd	Compound, composition and use
US5688258A (en)	1995-05-02	1997-11-18	The Procter & Gamble Company	Disposable cover for an absorbent materials
US6083903A (en) *	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
GB9500856D0 (en)	1995-01-17	1995-03-08	Zeneca Ltd	Composition and use
JPH09124620A (ja) *	1995-10-11	1997-05-13	Bristol Myers Squibb Co	置換ビフェニルスルホンアミドエンドセリン拮抗剤
US6766183B2 (en)	1995-11-22	2004-07-20	Medtronic Minimed, Inc.	Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers
WO1998024753A1 (fr)	1996-12-02	1998-06-11	Chisso Corporation	Derives de nitro-alcool actifs optiquement, derives d'amino-alcool actifs optiquement et leur procede de preparation
GB9604926D0 (en)	1996-03-08	1996-05-08	Sandoz Ltd	Organic compounds
AU3102697A (en)	1996-06-19	1998-01-07	Rhone-Poulenc Rorer Limited	Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
US5831046A (en)	1996-08-05	1998-11-03	Prolinx, Incorporated	Boronic acid-contaning nucleic acid monomers
WO1998012206A1 (en)	1996-09-19	1998-03-26	The Board Of Trustees Of Leland Stanford Jr. University	Dna adenine methyltransferases and uses thereof
US6221640B1 (en)	1997-05-14	2001-04-24	Cubist Pharmaceuticals, Inc.	Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
US6140328A (en)	1997-12-12	2000-10-31	Rutgers, The State University Of New Jersey	Heterocyclic cytotoxic agents
DE19829947A1 (de)	1998-07-04	2000-01-05	Bayer Ag	Elektrolumineszierende Anordnungen mit Bor-Chelaten
PL348210A1 (en)	1998-11-06	2002-05-06	Basf Ag	Tricyclic pyrazole derivatives
US6462036B1 (en)	1998-11-06	2002-10-08	Basf Aktiengesellschaft	Tricyclic pyrazole derivatives
WO2000044387A1 (fr)	1999-01-29	2000-08-03	Nitto Kasei Co., Ltd.	Composes organobores presentant une activite de coccidiostats
EP1181291A2 (en)	1999-05-25	2002-02-27	The Penn State Research Foundation	Dna methyltransferase inhibitors
DE60032614D1 (de)	1999-08-25	2007-02-08	Ambergen Inc	Verfahren zur erkennung, analyse und isolierung von freiwerdenden proteinen
US6306628B1 (en)	1999-08-25	2001-10-23	Ambergen, Incorporated	Methods for the detection, analysis and isolation of Nascent proteins
US6921763B2 (en) *	1999-09-17	2005-07-26	Abbott Laboratories	Pyrazolopyrimidines as therapeutic agents
US6369098B1 (en)	1999-10-05	2002-04-09	Bethesda Pharmaceuticals, Inc.	Dithiolane derivatives
AR029184A1 (es) *	2000-01-06	2003-06-18	Marantech Holding Llc	Composiciones farmaceuticas utiles para prevenir y/o tratar enfermedades dermatologicas y para facilitar y/o incrementar el crecimiento de la piel y los vendajes que comprenden dichas composiciones
US6521619B2 (en)	2000-06-29	2003-02-18	Icos Corporation	Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
CA2415938A1 (en)	2000-07-14	2002-01-24	Zycos Inc.	Alpha-msh related compounds and methods of use
AU2002227269A1 (en)	2000-11-07	2002-06-03	Bristol-Myers Squibb Company	Acid derivatives useful as serine protease inhibitors
ATE346074T1 (de)	2000-11-30	2006-12-15	Penn State Res Found	Dna methyl transferase inhibitoren
DE10110051C2 (de)	2001-03-02	2003-07-03	Clariant Gmbh	Verfahren zur Herstellung von Boron- und Borinsäuren
ATE438615T1 (de)	2001-04-06	2009-08-15	Biocryst Pharm Inc	Biarylverbindungen als serinproteaseinhibitoren
GB0117645D0 (en)	2001-07-19	2001-09-12	Isis Innovation	Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de)	2001-09-07	2003-03-27	Clariant Gmbh	Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
EP1444981A1 (en)	2001-10-11	2004-08-11	Katsuhiko Mikoshiba	Intracellular calcium concentration increase inhibitors
CN1325504C (zh)	2002-01-10	2007-07-11	宾夕法尼亚州研究基金会	制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法
US20040077601A1 (en)	2002-07-09	2004-04-22	Point Therapeutics, Inc.	Methods and compositions relating to isoleucine boroproline compounds
CA2504941C (en)	2002-11-08	2012-06-26	Neurogen Corporation	3-substituted-6-aryl pyridines
AU2003298328A1 (en)	2002-12-02	2004-06-23	Solvias Ag	Catalytic hydrogeneration of carbon-heteroatom double bonds
US7390806B2 (en)	2002-12-18	2008-06-24	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
AU2003299821B2 (en)	2002-12-18	2010-02-18	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
EP1613625A1 (en)	2003-03-14	2006-01-11	AstraZeneca AB	Novel fused triazolones and the uses thereof
WO2005000200A2 (en)	2003-05-09	2005-01-06	Sugen, Inc.	Novel kinases
MXPA05013848A (es) *	2003-06-16	2006-09-04	Anacor Pharmaceuticals Inc	Agentes terapeuticos que contienen boro hidroliticamente resistentes y metodos de uso.
JP2005022986A (ja) *	2003-06-30	2005-01-27	Sankyo Co Ltd	Ｅｄｇ受容体拮抗作用を有するアルキン誘導体
PT1643998E (pt)	2003-07-03	2007-11-21	Hoffmann La Roche	Antagonistas duplos dos receptores de nc1/nc3 para tratar a esquizofrenia
JP2007530450A (ja)	2003-12-29	2007-11-01	スリーエムイノベイティブプロパティズカンパニー	ピペラジン、［１，４］ジアゼパン、［１，４］ジアゾカン、および［１，５］ジアゾカン縮合イミダゾ環化合物
KR101300929B1 (ko)	2004-05-12	2013-08-27	더 브리검 앤드 우먼즈 하스피털, 인크.	감염 치료를 위한 겔솔린의 용도
AR049915A1 (es)	2004-06-14	2006-09-13	Anacor Pharmaceuticals Inc	Compuestos con contenido de boro y metodos de uso de los mismos
KR100624238B1 (ko)	2004-06-22	2006-09-19	한국화학연구원	알파-아릴메톡시아크릴레이트 유도체를 함유하는 대사성골 질환의 예방 및 치료용 약학 조성물
WO2006062731A1 (en)	2004-11-19	2006-06-15	University Of North Texas Health Science Center At Fort Worth	Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en)	2005-01-31	2005-03-09	Univ Cambridge Tech	Compounds for use in chemical detection and/or quantitation
MX369262B (es) *	2005-02-16	2019-11-04	Anacor Pharmaceuticals Inc	Moleculas pequeñas que contienen boro.
EP1856113B1 (en)	2005-03-08	2016-01-06	Agency for Science, Technology and Research	Chiral bisoxazoline catalysts
AR054336A1 (es)	2005-03-30	2007-06-20	Astion Dev As	Tratamiento de enfermedades dermatologicas y del prurito
US20080234229A1 (en)	2005-08-18	2008-09-25	Auspex Pharmaceuticals, Inc.	Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
WO2007078340A2 (en) *	2005-12-30	2007-07-12	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
CN103479654B (zh)	2006-02-16	2018-02-09	安纳考尔医药公司	作为抗炎药的含硼的小分子
US20070286822A1 (en)	2006-06-12	2007-12-13	Anacor Pharmaceuticals Inc.	Compounds for the Treatment of Periodontal Disease
WO2007146965A2 (en)	2006-06-12	2007-12-21	Anacor Pharmaceuticals, Inc.	Compounds for the treatment of periodontal disease
KR100848491B1 (ko)	2007-01-16	2008-07-28	영진약품공업주식회사	베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
KR100895300B1 (ko)	2007-07-20	2009-05-07	한국전자통신연구원	생체신호 측정의복과 생체신호 처리시스템
WO2009111676A2 (en)	2008-03-06	2009-09-11	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-inflammatory agents
EP3246034A1 (en)	2008-03-06	2017-11-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-inflammatory agents
EP2285384A4 (en)	2008-05-12	2012-04-25	Anacor Pharmaceuticals Inc	BORN SMALL MOLECULES
WO2010028005A1 (en)	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010045503A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents
WO2010045505A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-protozoal agents
AR088669A1 (es) *	2011-11-21	2014-06-25	Lilly Co Eli	Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
AR088668A1 (es) *	2011-11-21	2014-06-25	Lilly Co Eli	Moleculas pequeñas que contienen boro

2006
- 2006-02-16 MX MX2015007465A patent/MX369262B/es unknown
- 2006-02-16 HU HUE15171026A patent/HUE040060T2/hu unknown
- 2006-02-16 CN CN201010231477.2A patent/CN101914109B/zh active Active
- 2006-02-16 EP EP18187390.2A patent/EP3424932B1/en active Active
- 2006-02-16 PL PL15171026T patent/PL2987796T3/pl unknown
- 2006-02-16 DK DK15171026.6T patent/DK2987796T3/en active
- 2006-02-16 KR KR1020107017187A patent/KR101337068B1/ko active IP Right Grant
- 2006-02-16 ES ES11154575.2T patent/ES2540966T3/es active Active
- 2006-02-16 NZ NZ578297A patent/NZ578297A/en unknown
- 2006-02-16 PT PT15171026T patent/PT2987796T/pt unknown
- 2006-02-16 EP EP06735282.3A patent/EP1853251B1/en active Active
- 2006-02-16 PT PT181873902T patent/PT3424932T/pt unknown
- 2006-02-16 HU HUE11154575A patent/HUE026021T2/en unknown
- 2006-02-16 ES ES18187390T patent/ES2872962T3/es active Active
- 2006-02-16 PL PL11154575T patent/PL2343304T3/pl unknown
- 2006-02-16 EP EP11154575.2A patent/EP2343304B1/en active Active
- 2006-02-16 DK DK11154575.2T patent/DK2343304T3/en active
- 2006-02-16 AU AU2006214247A patent/AU2006214247C1/en active Active
- 2006-02-16 KR KR1020077021229A patent/KR101337045B1/ko active IP Right Grant
- 2006-02-16 CA CA2597982A patent/CA2597982C/en active Active
- 2006-02-16 SI SI200632404T patent/SI3424932T1/sl unknown
- 2006-02-16 SI SI200631937T patent/SI2343304T1/sl unknown
- 2006-02-16 NZ NZ598441A patent/NZ598441A/xx unknown
- 2006-02-16 EP EP15171026.6A patent/EP2987796B1/en active Active
- 2006-02-16 ZA ZA200707408A patent/ZA200707408B/xx unknown
- 2006-02-16 CN CNA2006800119809A patent/CN101160124A/zh active Pending
- 2006-02-16 PL PL18187390T patent/PL3424932T3/pl unknown
- 2006-02-16 DK DK18187390.2T patent/DK3424932T3/da active
- 2006-02-16 PT PT67352823T patent/PT1853251E/pt unknown
- 2006-02-16 HU HUE18187390A patent/HUE054365T2/hu unknown
- 2006-02-16 WO PCT/US2006/005542 patent/WO2006089067A2/en active Application Filing
- 2006-02-16 RU RU2007134429/04A patent/RU2414906C2/ru active
- 2006-02-16 BR BRPI0608431A patent/BRPI0608431B8/pt active IP Right Grant
- 2006-02-16 NZ NZ560448A patent/NZ560448A/en unknown
- 2006-02-16 PT PT111545752T patent/PT2343304E/pt unknown
- 2006-02-16 ES ES06735282T patent/ES2414095T3/es active Active
- 2006-02-16 JP JP2007555382A patent/JP5038912B2/ja active Active
- 2006-02-16 PL PL06735282T patent/PL1853251T3/pl unknown
- 2006-02-16 US US11/357,687 patent/US7582621B2/en active Active
- 2006-02-16 ES ES15171026.6T patent/ES2686981T3/es active Active
- 2006-02-16 KR KR1020137021530A patent/KR101456815B1/ko active Active
- 2006-02-16 KR KR1020137021906A patent/KR101426220B1/ko active Active
- 2006-02-16 SI SI200632291T patent/SI2987796T1/sl unknown
2007
- 2007-08-06 IL IL185080A patent/IL185080A/en active IP Right Grant
2008
- 2008-03-11 HK HK08102801.7A patent/HK1109735A1/xx unknown
- 2008-03-11 HK HK12100416.2A patent/HK1160139A1/xx not_active IP Right Cessation
2009
- 2009-07-21 US US12/507,010 patent/US8039451B2/en active Active
- 2009-08-27 ZA ZA2009/05950A patent/ZA200905950B/en unknown
2010
- 2010-07-20 AU AU2010203096A patent/AU2010203096C1/en active Active
- 2010-07-22 IL IL207156A patent/IL207156A/en active Protection Beyond IP Right Term
- 2010-07-28 ZA ZA2010/05380A patent/ZA201005380B/en unknown
- 2010-08-05 JP JP2010175989A patent/JP6046876B2/ja active Active
- 2010-08-10 RU RU2010133524A patent/RU2606947C2/ru active
2011
- 2011-03-01 AU AU2011200994A patent/AU2011200994A1/en not_active Abandoned
- 2011-09-01 US US13/224,252 patent/US8440642B2/en active Active
2012
- 2012-09-20 JP JP2012207001A patent/JP2013018778A/ja active Pending
2013
- 2013-04-30 US US13/874,329 patent/US8889656B2/en active Active
2014
- 2014-01-27 US US14/165,428 patent/US20140142064A1/en not_active Abandoned
- 2014-04-09 JP JP2014080464A patent/JP2014132031A/ja active Pending
- 2014-11-10 US US14/537,694 patent/US20150065459A1/en not_active Abandoned
2015
- 2015-09-17 ZA ZA2015/06944A patent/ZA201506944B/en unknown
- 2015-09-24 JP JP2015187408A patent/JP2016020374A/ja active Pending
- 2015-12-21 US US14/977,052 patent/US20160108063A1/en not_active Abandoned
2016
- 2016-08-23 HK HK16110032.1A patent/HK1221956A1/zh unknown
- 2016-11-18 US US15/355,813 patent/US20170066788A1/en not_active Abandoned
- 2016-11-23 RU RU2016145916A patent/RU2016145916A/ru not_active Application Discontinuation
2017
- 2017-02-15 JP JP2017025789A patent/JP2017105826A/ja active Pending
2018
- 2018-09-18 CY CY181100962T patent/CY1120695T1/el unknown
- 2018-10-18 US US16/164,331 patent/US20190048026A1/en not_active Abandoned
2019
- 2019-07-12 US US16/510,135 patent/US20190330245A1/en not_active Abandoned
2020
- 2020-06-08 LU LU00157C patent/LUC00157I2/fr unknown
- 2020-06-23 FR FR20C1024C patent/FR20C1024I2/fr active Active
- 2020-06-24 NL NL301049C patent/NL301049I2/nl unknown
- 2020-06-25 HU HUS2000019C patent/HUS2000019I1/hu unknown
- 2020-07-30 CY CY2020027C patent/CY2020027I1/el unknown
- 2020-08-14 LT LTPA2020524C patent/LTC2343304I2/lt unknown
- 2020-11-16 US US17/098,636 patent/US20210070780A1/en not_active Abandoned
2021
- 2021-05-19 CY CY20211100432T patent/CY1124503T1/el unknown

Also Published As

Publication number	Publication date
EP3424932A1 (en)	2019-01-09
BRPI0608431B8 (pt)	2021-05-25
ZA201005380B (en)	2016-08-31
US20110319361A1 (en)	2011-12-29
CY1120695T1 (el)	2019-12-11
EP2987796B1 (en)	2018-08-08
KR20100105869A (ko)	2010-09-30
NZ598441A (en)	2013-07-26
CA2597982A1 (en)	2006-08-24
US20060234981A1 (en)	2006-10-19
US20150065459A1 (en)	2015-03-05
ES2872962T3 (es)	2021-11-03
EP2343304A1 (en)	2011-07-13
KR101456815B1 (ko)	2014-10-31
IL207156A (en)	2014-04-30
FR20C1024I2 (fr)	2021-07-09
KR20130095330A (ko)	2013-08-27
EP2343304B1 (en)	2015-06-10
KR101426220B1 (ko)	2014-08-05
SI2987796T1 (sl)	2018-11-30
CY1124503T1 (el)	2022-07-22
EP1853251B1 (en)	2013-04-24
AU2006214247B2 (en)	2010-08-05
ZA200707408B (en)	2009-11-25
US20170066788A1 (en)	2017-03-09
BRPI0608431A2 (pt)	2009-12-29
FR20C1024I1 (pl)	2020-07-31
AU2010203096B2 (en)	2010-12-02
US20210070780A1 (en)	2021-03-11
KR101337045B1 (ko)	2013-12-05
NZ560448A (en)	2009-08-28
RU2016145916A3 (pl)	2020-07-21
ES2540966T3 (es)	2015-07-15
JP6046876B2 (ja)	2016-12-21
KR101337068B1 (ko)	2013-12-06
US20190048026A1 (en)	2019-02-14
JP5038912B2 (ja)	2012-10-03
DK2987796T3 (en)	2018-09-17
CA2597982C (en)	2014-07-08
LUC00157I2 (pl)	2021-07-06
CN101914109B (zh)	2014-07-23
AU2010203096A1 (en)	2010-08-12
PL3424932T3 (pl)	2021-09-20
LTPA2020524I1 (lt)	2020-09-10
JP2016020374A (ja)	2016-02-04
HUS2000019I1 (hu)	2020-07-28
AU2006214247C1 (en)	2012-11-08
DK2343304T3 (en)	2015-06-29
EP1853251A2 (en)	2007-11-14
US20100190748A1 (en)	2010-07-29
ZA200905950B (en)	2010-11-24
RU2010133524A (ru)	2012-02-20
CN101160124A (zh)	2008-04-09
KR20130100019A (ko)	2013-09-06
NZ578297A (en)	2010-11-26
SI3424932T1 (sl)	2021-08-31
IL185080A0 (en)	2008-08-07
JP2013018778A (ja)	2013-01-31
ZA201506944B (en)	2018-08-29
JP2014132031A (ja)	2014-07-17
PL2987796T3 (pl)	2018-12-31
ES2414095T3 (es)	2013-07-18
KR20070112390A (ko)	2007-11-23
PT2987796T (pt)	2018-10-18
EP2987796A1 (en)	2016-02-24
HK1109735A1 (en)	2008-06-20
US7582621B2 (en)	2009-09-01
US8039451B2 (en)	2011-10-18
US20160108063A1 (en)	2016-04-21
EP1853251A4 (en)	2010-01-13
PT3424932T (pt)	2021-05-19
US8440642B2 (en)	2013-05-14
WO2006089067A2 (en)	2006-08-24
NL301049I2 (nl)	2020-09-10
WO2006089067A3 (en)	2007-07-19
PT1853251E (pt)	2013-07-19
US20130244980A1 (en)	2013-09-19
CY2020027I2 (el)	2021-01-27
HUE026021T2 (en)	2016-05-30
RU2016145916A (ru)	2018-05-23
CN101914109A (zh)	2010-12-15
JP2017105826A (ja)	2017-06-15
AU2011200994A1 (en)	2011-03-31
NL301049I1 (nl)	2020-07-01
HK1221956A1 (zh)	2017-06-16
US20190330245A1 (en)	2019-10-31
HK1160139A1 (en)	2012-08-10
BRPI0608431B1 (pt)	2020-09-15
US20140142064A1 (en)	2014-05-22
CY2020027I1 (el)	2021-01-27
LUC00157I1 (pl)	2020-06-08
JP2008535781A (ja)	2008-09-04
RU2606947C2 (ru)	2017-01-10
IL185080A (en)	2012-07-31
HUE040060T2 (hu)	2019-02-28
DK3424932T3 (da)	2021-05-25
JP2010248265A (ja)	2010-11-04
RU2414906C2 (ru)	2011-03-27
LTC2343304I2 (lt)	2022-11-10
AU2006214247A1 (en)	2006-08-24
RU2007134429A (ru)	2009-03-27
AU2010203096C1 (en)	2012-09-20
ES2686981T3 (es)	2018-10-23
SI2343304T1 (sl)	2015-08-31
US8889656B2 (en)	2014-11-18
PT2343304E (pt)	2015-08-26
EP3424932B1 (en)	2021-04-07
PL2343304T3 (pl)	2015-09-30
MX369262B (es)	2019-11-04
HUE054365T2 (hu)	2021-09-28

Publication	Publication Date	Title
HK1221956A1 (zh)	2017-06-16	用於治療感染的鹵代類苯酞化硼
IL187999A0 (en)	2008-03-20	Compositions for the treatment of persistent infections
AP2007004128A0 (en)	2007-08-31	Tricyclic-nucleoside compounds for treating viral infections
GB0513552D0 (en)	2005-08-10	Bandage
IL191379A (en)	2014-01-30	sewage care
IL187581A0 (en)	2008-03-20	Compounds for the treatment of multi-drug resistant bacterial infections
ZA200709875B (en)	2008-11-26	Loincloth diaper
IL190913A0 (en)	2009-02-11	Methods for the treatment of hyperhidrosis
PL1951334T3 (pl)	2016-04-29	Laktator
IL186408A0 (en)	2008-08-07	Combination treatment methods
ZA200708033B (en)	2008-11-26	Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
PL1959957T3 (pl)	2012-12-31	Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
HK1097831A1 (en)	2007-07-06	Benzopyran compounds useful for the treatment of arrhytmia
GB0524103D0 (en)	2006-01-04	Healing
GB0513096D0 (en)	2005-08-03	Treatment of microbial infections
GB0518508D0 (en)	2005-10-19	Treatment of waste
GB0621587D0 (en)	2006-12-06	Sludge treatment
GB0516068D0 (en)	2005-09-14	Well treatment
IL187792A0 (en)	2008-11-03	4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0511769D0 (en)	2005-07-20	Treatment
GB0525540D0 (en)	2006-01-25	New treatment
GB0517387D0 (en)	2005-10-05	Combinations for the treatment of cancer
ZA200805522B (en)	2009-04-29	Dioxoiane dérivates for the treatment of cancer
EP1841457A4 (en)	2008-11-12	TARGET APHERESIS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
GB0502171D0 (en)	2005-03-09	Well treatment